|
- IRMS - Nicolae Testemitanu SUMPh
- 1. COLECȚIA INSTITUȚIONALĂ
- MedEspera: International Medical Congress for Students and Young Doctors
- MedEspera 2020
Please use this identifier to cite or link to this item:
http://hdl.handle.net/20.500.12710/11750
Title: | Intrahepatic cholestasis of pregnancy. Diagnosis. Maternal and fetal complications |
Authors: | Butucel, Ana |
Keywords: | intrahepatic cholestasis of pregnancy;idiopathic jaundice of pregnancy;pruritus gravidarum;diagnosis of intrahepatic cholestasis of pregnancy;outcome on intrahepatic cholestasis of pregnancy |
Issue Date: | 2020 |
Publisher: | MedEspera |
Citation: | BUTUCEL, Ana. Intrahepatic cholestasis of pregnancy. Diagnosis. Maternal and fetal complications. In: MedEspera: the 8th Internat. Medical Congress for Students and Young Doctors: abstract book. Chișinău: S. n., 2020, p. 175-176. |
Abstract: | Introduction. Intrahepatic cholestasis of pregnancy (ICP) is a cholestatic disorder
characterized by pruritus, elevated serum aminotransferases and bile acid levels with onset in
the second or third trimester of pregnancy, and spontaneous relief of signs and symptoms
within two to three weeks after delivery. ICP has been observed in almost all ethnic groups,
but there is relevant geographical variation in the incidence of ICP varying from less than 1%
to 27.6%. It is important to diagnose it in time because of its effects on pregnancy outcome.Aim of the study. This review was undertaken to find the criteria of diagnosis and to evaluate
the possible maternal and fetal complications.
Materials and methods. To identify relevant articles, NCBI and ScienceDirect databases were
searched using the Key words: “intrahepatic cholestasis of pregnancy”, “Idiopathic jaundice of
pregnancy”, “Pruritus gravidarum”, “diagnosis of intrahepatic cholestasis of pregnancy”,
“outcome on intrahepatic cholestasis of pregnancy”.
Results. This study concluded that Pruritus is the primary clinical symptom of ICP. It usually
presents in the third trimester, after 30 weeks of gestation, but rare cases developing early. The
diagnosis of ICP is based on pruritus of cholestasis, elevated fasting serum bile acids > 10
μmol/L (± and elevated serum transaminases), spontaneous relief of signs and symptoms within
two to three weeks after delivery and absence of other diseases that cause pruritus and jaundice.
Mild jaundice with serum levels of conjugated bilirubin only moderately elevated occurs in 10 to 15% of cases. ICP presents a greater risk to the fetus than to the mother. ICP increases the
rate of preterm delivery with the associated mortality and morbidity, meconium-stained
amniotic fluid. In addition, the fetus seems to be at an increased risk for stillbirth. The major
concern for the mother is for postpartum hemorrhage if her vitamin K level is low, leading to
an increase in prothrombin time. Also women with ICP are more likely to have gestational
diabetes, pre-eclampsia, spontaneous and iatrogenic preterm delivery, with increased rates of
induction of labour.
Conclusions. ICP, especially severe ICP is associated with adverse pregnancy outcome.
Pregnant women should be diagnosed in an efficient time for adopting the appropriate
management to prevent complications as much as possible. |
URI: | http://repository.usmf.md/handle/20.500.12710/11750 medespera.asr.md/wp-content/uploads/ABSTRACT-BOOK.pdf |
Appears in Collections: | MedEspera 2020
|
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.
|